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Abstract
Bordetella spp. form biofilms in the mouse nasopharynx, thereby providing a potential mechanism for establishing chronic
infections in humans and animals. Filamentous hemagglutinin (FHA) is a major virulence factor of B. pertussis, the causative
agent of the highly transmissible and infectious disease, pertussis. In this study, we dissected the role of FHA in the distinct
biofilm developmental stages of B. pertussis on abiotic substrates and in the respiratory tract by employing a murine model
of respiratory biofilms. Our results show that the lack of FHA reduced attachment and decreased accumulation of biofilm
biomass on artificial surfaces. FHA contributes to biofilm development by promoting the formation of microcolonies.
Absence of FHA from B. pertussis or antibody-mediated blockade of surface-associated FHA impaired the attachment of
bacteria to the biofilm community. Exogenous addition of FHA resulted in a dose-dependent inhibitory effect on bacterial
association with the biofilms. Furthermore, we show that FHA is important for the structural integrity of biofilms formed on
the mouse nose and trachea. Together, these results strongly support the hypothesis that FHA promotes the formation and
maintenance of biofilms by mediating cell-substrate and inter-bacterial adhesions. These discoveries highlight FHA as a key
factor in establishing structured biofilm communities in the respiratory tract.
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Introduction
Bordetella pertussis is the major causative agent of whooping cough
(pertussis), a highly infectious and transmissible disease of the
human upper respiratory tract. Over the past two decades
pertussis has experienced a resurgence worldwide [1]. While
pertussis is traditionally described as a severe childhood disease, it
is also common among adolescents and adults, in whom it often
manifests as persistent cough with milder symptoms [2,3]. A large
body of evidence strongly supports that adolescents and adults as
reservoirs and sources of pertussis transmission [4,5,6,7]. In a
recent population based study conducted over a period of about
two years in the Netherlands, 53% of the household contacts had
laboratory-confirmed pertussis. Strikingly, in 60% of the house-
holds, the source of transmission to infants was clearly established
to be one of the family members [8].
We recently began to explore the capacity of B. pertussis to form
biofilms, postulating that this pathogen adopts the biofilm lifestyle
as a strategy to survive in the human respiratory tract [9,10,11,12].
A biofilm is a complex community-based mode of existence that
microbes establish over abiotic or living surfaces [13]. This lifestyle
confers upon pathogens several advantageous traits linked to
virulence, including resistance to environmental stress, host
defences and antimicrobial compounds [14,15]. Such virulence-
related traits ultimately facilitate the establishment of persistent
infections or a carrier state [16]. The existence of a biofilm mode
of life for B. pertussis and its closely related species B. bronchiseptica in
the mouse respiratory tract has been demonstrated [9,10,17]. One
of the strengths of this model is that the Bordetella cells attached to
the respiratory epithelium are surrounded by a self-produced
extracellular matrix composed of the Bps polysaccharide, thereby
satisfying the definition of in vivo biofilms. Moreover, B. pertussis has
been found adherent to ciliated cells of explant cultures and in
tissue biopsies of pertussis patients in the form of clusters and
tangles (structures reminiscent of biofilms) [18,19,20]. Taken
together, while these results suggest an important role for the B.
pertussis biofilm state in human infections, the knowledge of the
events and factors involved in this lifestyle is rudimentary.
Biofilm development depends on the ability of microorganisms
to establish cell-substrate and cell-cell interactions, since they
support sessile growth and the development of multicellular
structures [21]. To promote these interactions, most biofilm-
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fimbriae, Type IV pili, outer membrane proteins or exopolymers
like polysaccharides [22,23,24,25,26,27,28]. B. pertussis produces
various factors implicated in bacterial attachment, which promote
sequential and/or redundant interactions with host epithelia in the
respiratory tract. Among such factors are adhesins like filamentous
hemagglutinin (FHA), pertactin and fimbriae [29]. FHA is a large,
b-helical, highly immunogenic protein that is both surface
associated and secreted [30]. FHA displays diverse attachment
activities derived from its multiple binding domains, which
facilitate Bordetella attachment to a variety of eukaryotic cell types
and extracellular structures in the respiratory epithelium [31].
Other documented roles include mediating B. pertussis invasion to
host cells, triggering immunomodulatory responses and promoting
autoagglutination and colonization of the respiratory tract [32,33,
34,35,36,37,38]. FHA is the prototypical member of the family of
bacterial proteins secreted by the two-partner secretion system
[39]. Two members of this family, CdrA in P. aeruginosa and
XacFhaB in Xanthomonas axonopodis pv. Citri have recently been
shown to be involved in biofilm formation [40,41].
Thus, although the existing literature justifies consideration of
FHA as a candidate for biofilm adhesin, there is little known on its
potential role in biofilm formation. It has been shown that FHA
contributes to biofilm formation by the animal pathogen B.
bronchiseptica [36,42]. In the case of the human pathogen B. pertussis,
the role of this protein factor has remained unexplored. Moreover,
the mechanism by which FHA contributes to biofilm formation in
either B. bronchiseptica or B. pertussis is unknown.
In the present study, we investigated the mechanism by which
B. pertussis FHA mediates the different steps of biofilm develop-
ment on abiotic surfaces. We show that FHA is a key factor for
bacterial attachment and subsequent cell accumulation on
substrates. Our results indicated that surface-associated FHA
promotes the formation of structured biofilms by mediating inter-
bacterial adhesion. We extended our in vitro observations by
investigating the function of FHA in biofilm formation in the
mouse respiratory tract. Absence of FHA caused a significant
reduction in the ability of B. pertussis to form and maintain biofilm-
like structures in the mouse nose and the trachea. Together our
results highlight the role of FHA as a central structural factor in B.
pertussis biofilm development. We propose that FHA-mediated
biofilm formation in the respiratory tract allows B. pertussis to evade
the host immune response thereby establishing a bacterial
reservoir in the human respiratory tract.
Results
B. pertussis FHA is required for biofilm formation on
abiotic surfaces
No information is available on the role of FHA in contributing
to the biofilm development of B. pertussis. We initiated this study by
utilizing a previously described glass column culture system packed
with polypropylene beads (the growth support) [11] to examine
biofilm formation under aeration conditions. The wild-type (WT)
strain BPSM, a Tohama I derivative, and the isogenic DfhaB
mutant, BPGR4, which carries a chromosomal deletion of the
FHA structural gene fhaB [43], were similarly cultured in this
system for 72 and 96 h. We have previously shown that within this
time frame of cultivation, B. pertussis biofilms gain structural
maturity [11,44]. The biofilm biomass for the two strains was
quantified by crystal violet staining and measuring the absorbance
of the solubilized stain at 590 nm. Compared to the WT strain, the
DfhaB mutant was defective in its ability to form biofilms after 72 h
of growth. Even after 4 days, the mutant strain displayed
significantly reduced capacity to accumulate biofilm biomass
(Fig. 1A). Similar results were obtained when borosilicate beads
were used as growth support (data not shown). We also confirmed
the crystal violet staining results by determining the number of
viable sessile cells of each strain recovered from the polypropylene
beads at the end of the experiment (96 h). The number of CFUs
obtained for the mutant strain was significantly lower than that
obtained for the WT strain (P,0.05, t test) (Fig. 1B). The observed
differences in surface-attachment between the WT and the DfhaB
strains were not due to their differential ability to grow either
planktonically or in shaking cultures. The number of DfhaB cells
present in the bulk-liquid phase at 96 h was not significantly
different from that of the WT strain (P=0.11, t test) (Fig. 1C).
Moreover, these two strains exhibited similar specific growth rates
in shaking cultures (data not shown). These results suggest that
FHA contributes to the formation of biofilms by B. pertussis.
The biofilm-forming defect of the DfhaB mutant derives
from its impaired capacity to interact with the substrate
during attachment, and subsequent stages of
development
Biofilm development in bacteria is a multi-stage process and
results from initial surface attachment of bacterial cells followed by
accumulation into multilayered cell clusters. We therefore asked
whether the observed biofilm defect of the DfhaB mutant resulted
from defects in initial attachment. To investigate this, we first
compared the attachment of GFP-tagged derivatives of both the
WT and the DfhaB strains to glass coverslips by fluorescence
microscopy. In order to allow the bacteria present in the liquid
phase to reach the substrate, a 4-h incubation period was
established for assaying attachment. Note that this time period is
shorter than the doubling time of both the B. pertussis strains (data
not shown) and thus the attachment is considered independent
from growth. Images in Fig. 2A show that after 4 h of incubation,
a greater number of GFP-tagged cells of the WT strain remained
attached to the surface relative to that for similarly tagged DfhaB
mutant. In parallel, we also examined the attachment of the WT
and the DfhaB strains to polypropylene beads. The adhered cell
biomass was quantified by crystal violet staining. Results show that
after 4 h of incubation, the DfhaB mutant exhibited a significantly
reduced percentage of cell biomass adhering to polypropylene
beads compared to that of the WT strain (Fig. 2B, compare first
and second white bars).
While these results indicate that FHA is necessary for efficient
initial attachment of B. pertussis to the surface, they do not provide
information on the extent to which the observed attachment
defect, resulting from the absence of FHA, affects subsequent steps
of biofilm formation. Thus, we next investigated whether a low
number of adherent bacteria, similar to that found for the DfhaB
mutant strain (Fig. 2B, second white bar), was sufficient to result in
a late-stage biofilm. To this end, the number of WT bacteria in the




Inoculated bacteria were allowed to attach for 4 h followed by
incubation under normal biofilm culture conditions. Under these
conditions, while the WT strain was capable of forming biofilms
(Fig. 2B, third black bar), the DfhaB mutant did not show an
increase in the biofilm biomass (Fig. 2B, second black bar). We also
confirmed the crystal violet staining results by determining the
number of viable cells of each strain recovered from the
polypropylene beads in the same experiment (Fig. 2C). Together
these results suggest that the absence of FHA renders B. pertussis
not only deficient in early attachment, but also in the
accumulation of the biofilm biomass.
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correlates with defects in the formation of structured cell
clusters
The absence of FHA strongly diminished, but did not fully
abolish biofilm accumulation. To better understand the function of
FHA in biofilm development, structural aspects of this mode of
growth were examined. GFP-tagged WT and mutant strains were
cultured in continuous-flow chamber systems. These systems offer
dynamic flow conditions, which allow the continuous replenish-
ment of nutrients, as well as analytical advantages like non-
invasive real-time monitoring of structural development of biofilms
by microscopy techniques. At indicated time points, biofilm
formation of each strain was examined in situ by fluorescence
microscopy. As has been previously shown [10,12], by 24 h, the
WT strain was adherent to the glass surface in a diffused manner
and formed small clusters of cells (Fig. 3A). Between 48 and 72 h
of cultivation, the density of surface attached WT cells increased
and at this stage biofilms appeared structurally complex. Cells
were observed to be arranged in large and irregularly shaped
microcolonies attached to the surface. In contrast, a reduced
number of DfhaB mutant cells were attached to the coverslips at
24 h with no visible cell clusters. With time, while the number of
DfhaB mutant cells attached to the borosilicate surface slightly
increased, structures resembling those of the WT biofilm were
never observed. The increase in biomass for the mutant strain
mainly correlated with the presence of single cells dispersed over
the surface or with the formation of diffuse small cell clusters.
These data suggest that the DfhaB mutant is not only delayed in
biofilm formation but is unable to form a typical structured biofilm
community.
To gain information on the differences in the structural features
of the biofilms formed by the WT and the mutant strains, 72-h-old
biofilms were examined by Confocal Laser Scanning Microscope
(CLSM). Stacks of Z-section images were collected and recon-
structed into 3D images. As observed in Fig. 3B, after 72 h of
growth, the WT strain formed robust biofilms consisting of large
tower-shaped cell aggregates. In contrast, the mutant strain
developed minute clusters across the whole substrate. These
Figure 1. Biofilm formation by WT (BPSM) and DfhaB (BPGR4) B. pertussis strains on abiotic surfaces. Biofilm cultures were performed in
glass column systems containing polypropylene beads. (A) Biofilm biomass accumulated by each strain over the polypropylene beads after 72 and
96 h of cultivation was stained with CV 0.1% (v v
21). The CV stain associated with cells was solubilized in ethanol/acetone (80:20) and the resulting
solution was subjected to measurement of the absorbance at 590 nm. The data are the means 6 standard deviations of three independent
experiments. An asterisk indicates significant differences between the WT and the DfhaB mutant (P value ,0.05; Student’s t-test). (B) Viable cell
counts of the biofilm cells of each strain. The adhered cells were gently washed and detached from the polypropylene beads by slight agitation in
PBS buffer. Serial dilutions of cell suspensions were then plated on BGA plates. Results are expressed as the number of colony-forming units per unit
area (CFUs cm
22). The data are the means 6 standard deviations of three independent experiments. An asterisk indicates significant differences
between the WT and the DfhaB mutant (P value ,0.05; Student’s t-test). (C) Viable cell counts of the planktonic cells in the bulk-liquid phase of
biofilm cultures of each strain. The cells were drained out of the biofilm column system at the end of the experiment (96 h). Serial dilutions of cell
suspensions were then plated on BGA plates. Results are expressed as the number of colony-forming units per unit volume (CFUs ml
21). The data are
the means 6 standard deviations of three independent experiments.
doi:10.1371/journal.pone.0028811.g001
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which allowed us to extract quantitative information of biofilm
architecture [45]. The descriptors chosen were: mean and
maximum thickness, total biomass, and the mean size of cell
clusters (microcolonies). Biofilms developed by the WT strain
exhibited a mean thickness of 25 mm and a maximum thickness of
approximately 48 mm (Table 1). In contrast, the DfhaB strain
formed a non-uniform layer of cells on the surface with a mean
thickness of only 2.5 mm and maximum thickness of about 4 mm.
Comparison of the biomass values also showed significant
differences in the density of cells accumulated on the surface
between the two strains. Similarly, computation of the average of
the mean area of cell clusters located at the substratum showed
that the DfhaB mutant formed only small cell clusters as compared
to the WT strain (Table 1). In conclusion, COMSTAT analyses of
CLSM image stacks of the biofilms suggest that FHA is critical for
the development of the three-dimensional architecture of B.
pertussis biofilms, as evidenced by the thick and voluminous
biofilms produced by the WT strain compared to the relatively
flat, dispersed and monolayer-like mat of cells produced by the
DfhaB strain.
The presence of FHA on the surface of B. pertussis cells is
necessary to mediate the formation of biofilms
From the above results, it is clear that FHA is involved not only
in the interaction of B. pertussis with surfaces, but also in the
formation of multicellular cell clusters. We hypothesized that FHA
may facilitate inter-bacterial adhesion, thereby resulting in the
formation of microcolonies and eventual development of mature
biofilms. To examine this hypothesis, we first investigated if the
presence of this protein on the bacterial surface was needed to
integrate bacteria into the biofilm community. We compared
biofilms formed by mixtures of the WT and the DfhaB strains
carrying different antibiotic resistance genes. The CFUs of each
strain in the mixed biofilms were enumerated by plating on
selective BGA plates. When WT (B213[pGFP], Gm
r) and DfhaB
(BPGR4, Nal
r) strains were simultaneously co-cultured in biofilm,
the population of cells recovered after 72 h was mainly composed
Figure 2. Early attachment of B. pertussis strains to abiotic surfaces. (A) Attachment of WT and DfhaB strains to glass. Inoculated bacteria
(1610
9 CFUs ml
21) were allowed to attach to the surface under static conditions for 4 h at 37uC. Fluorescence images of WT and DfhaB GFP-tagged
cells that remained adhered to the glass coverslips. (B) Attachment and subsequent biofilm growth by the WT and DfhaB B. pertussis strains. WT and
DfhaB biofilm cultures were initiated with high inoculum levels (1610
9 CFUs ml
21). Bacteria were allowed to attach for 4 h followed by incubation
under normal biofilm culture conditions. The effect of low-level attachment on subsequent biofilm formation by the WT B. pertussis strain was also
examined. The number of WT bacteria in the inoculum was reduced from 1610
9 to 4610
8 CFUs ml
21 so as to decrease the population of cells
initially adhered to the level displayed by the DfhaB strain with a high inoculum (1610
9 CFUs ml
21), and then incubated under normal biofilm culture
conditions. Adhered biomass was stained with CV 0.1% (v v
21). The CV stain associated with cells was solubilized in ethanol/acetone (80:20) and the
resulting solution was subjected to measurement of the absorbance at 590 nm. The data are the means 6 standard deviations of three independent
experiments. An asterisk indicates significant differences between attachment and biofilm growth (P value ,0.05; Student’s t-test). (C) Viable cell
counts of the adhered cells of each strain to polypropylene beads under the conditions described in B. The adhered cells were gently washed and
detached from the polypropylene beads by slight agitation in PBS buffer. Serial dilutions of cell suspensions were then plated on BGA plates. Results
are expressed as the number of colony-forming units per unit area (CFUs cm
22). The data are the means 6 standard deviations of three independent
experiments. An asterisk indicates significant differences between attachment and biofilm growth (P value ,0.05; Student’s t-test).
doi:10.1371/journal.pone.0028811.g002
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28811Figure 3. Microscopy analysis of biofilm formation by the WT and the DfhaB strains. GFP-tagged strains were inoculated directly in the
continuous-flow chambers. Bacteria were allowed to attach for 4 h at 37uC, and then the sterile SS medium was pumped through the flow chambers
at a flow rate of 0.1 ml min
21. The experiment was repeated at least three times. Biofilms were visualized in situ by fluorescence and CLSM
microscopy. (A) Representative fluorescence micrographs of biofilms taken every 24 h for 3 days at a magnification of 6400. (B) Volumetric 3D
reconstructions of representative Z-section image stacks of biofilms taken at 72 h of growth at a magnification of 6306. For each strain, images are
presented in two different perspectives.
doi:10.1371/journal.pone.0028811.g003




b Strain WT (BPSM[pGFP]) DfhaB (BPGR4[pGFP]) P value
c
Maximum thickness (mm) 47.6 (0.84) 3.82 (0.18) 1.1 10
27





22) 5.28 (0.53) 1.29 (0.20) 0.0003
Mean cell cluster area
e (mm
2) 426.75 (95.9) 14.54 (2.88) 0.0016
aBiofilms were grown on the base of flow chambers under continuous flow conditions.
CLSM images stacks were acquired from random points by using a plan-neofluar6100/1.3 oil immersion objective, at 1 mm z-intervals down through the biofilm. Image
stacks were analyzed by COMSTAT.
bAverage values of parameters obtained from COMSTAT analysis of six CLSM image stacks derived from three independent experiments. Standard errors are given in
parentheses.
cP values were determined using an unpaired two-tailed Student’s t-test.
dThe value is biomass volume divided by substratum area.
eThe function calculates the mean area size of cell clusters located at the substratum.
doi:10.1371/journal.pone.0028811.t001
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when the two WT strains with different antibiotic resistance
(B213[pGFP] Gm
r and BPSM Nal
r) were co-inoculated, the
fractions of cells of each strain recovered from the mixed biofilm
were not substantially different (Table 2). Competition growth
experiments carried out in parallel as control showed that the
growth rate of each strain was not affected by the presence of the
other strain (data not shown). Moreover, both the WT strains,
B213 and BPSM, which were derived from Tohama I, exhibited
similar growth in shaking cultures (Fig. S1) and accumulate biofilm
biomass at similar levels (Fig. S2). It has also been previously
shown that the plasmid CW504, herein called pGFP, does not
affect either growth or FHA expression of Bordetella [46,47,48].
Data presented in Fig. S3 further show that the presence of the
pGFP plasmid does not affect the biofilm forming ability of B.
pertussis.
We also examined whether the DfhaB strain could be integrated
into an established biofilm formed by the WT strain. To test this,
WT (B213[pGFP], Gm
r) was cultured for 24 h on polypropylene
beads as described below. After 24 h of incubation, equal numbers
of either the DfhaB (BPGR4, Nal
r) or the WT (BPSM, Nal
r) cells
were inoculated into the culture system and cultured for an
additional 48 h. Results showed in Table 2 indicate that even
when co-cultured sequentially, the DfhaB mutant was severely
impaired in its capacity to be integrated into pre-existing biofilms.
On the contrary, co-inoculated WT (BPSM, Nal
r) cells were found
to be incorporated into the biofilm initiated by another WT
(B213[pGFP], Gm
r) strain, although to a lesser extent compared to
when they were inoculated simultaneously. Taken together, these
results suggest that the presence of FHA on the cell surface is
needed for the bacteria to become part of the biofilm community.
These results also suggest that surface-associated FHA on the WT
bacterial cell does not compensate for this protein on the surface of
a FHA-deficient bacterium.
Inhibition of the attachment of B. pertussis cells to the
biofilm by anti-FHA serum
To further substantiate the role of surface-associated FHA in
mediating bacterial association with the biofilms, we examined the
effect of anti-FHA serum on the attachment of Bordetella cells to the
biofilms. GFP-tagged planktonic bacteria of the WT strain were
pre-incubated with different dilutions of the anti-FHA serum and
allowed to attach to 24-h-old biofilm of the same strain. The
attachment level was determined by visualizing and enumerating
the GFP-expressing bacteria that colocalized with the biofilms.
Untreated WT bacteria attached uniformly to the pre-existing
biofilm microcolonies (Fig. 4A). On an average, 8.661.2 GFP-
tagged WT cells were found to adhere per 100 mm
2 of pre-formed
WT biofilm microcolony. Pre-incubation of GFP-tagged WT
bacteria with anti-FHA serum resulted in a decrease of bacterial
attachment to the pre-formed biofilms in a dose-dependent fashion
(Fig. 4B). Maximum decrease in adherence was obtained at the
1:250 dilution of the serum, which resulted in an average of
0.5960.3 attached cells/100 mm
2 of WT biofilm microcolony.
Next, we determined if FHA present on the surface of the
biofilm bacteria contributed to the attachment of planktonic
bacteria to the biofilms. To test this, 24-h-old WT biofilms were
pre-incubated with the anti-FHA serum, and then subjected to a 4-
h incubation period with planktonic GFP-tagged WT bacteria
(Fig. 4C). At the 1:250 dilution of the anti-FHA serum, only
1.2160.5 GFP-tagged WT cells/100 mm
2 of WT biofilm micro-
colony were found to be attached. Control experiments where
either the planktonic or the biofilm bacteria were pre-incubated
with normal sheep serum did not interfere with the adherence of
planktonic WT bacteria to the biofilms (Fig. S4). Moreover, pre-
incubation of DfhaB planktonic cells with the anti-FHA serum did
not further reduce the observed low level of attachment of the
DfhaB mutant (data not shown). In combination, these results
argue that the presence of FHA on the surface of both the
planktonic and the biofilm bacteria is required for promoting the
association of the bacterial cells with the Bordetella biofilms.
Addition of exogenous FHA prevents association with
the biofilms
Based on the above results, we hypothesized that externally
added FHA will bind to surface-associated FHA and block inter-
bacterial adhesion. To test this, we evaluated the extent to which
GFP-tagged planktonic bacteria of the WT strain, pre-incubated
with different concentrations of purified FHA, attach to 24-h-old
biofilms of the same strain. As indicated above, the attachment
level was determined by visualizing and enumerating the GFP-
expressing bacteria that colocalize with the biofilms. We found
that the attachment of planktonic WT bacteria to the biofilms
decreased in response to increasing concentration of FHA (Fig. 5).
Under the assay conditions, maximum effect of FHA in reducing
the attachment of WT bacteria was observed at a concentration of
20 mgm l
21. In parallel, control experiments were conducted with
either the DfhaB strain or with BSA. Compared to the WT strain,
the DfhaB mutant exhibited a low level of attachment, which could
not be further reduced by pre-incubation with 20 mgm l
21 FHA
(Fig. 5). Likewise, pre-incubation of planktonic bacteria of the WT
strain or the DfhaB strain with 20 mgm l
21 BSA resulted in
Table 2. Quantification of bacteria recovered during simultaneous and sequential co-inoculation biofilm assays
a.
Co-inoculated strains
Mode and time of inoculating strain B
(Time; h)




r) DfhaB (BPGR4; Nal
r) Simultaneous (0) 0.91/0.09
WT (B213[pGFP], Gm
r) WT (BPSM; Nal
r) Simultaneous (0) 0.56/0.44
WT (B213[pGFP], Gm
r) DfhaB (BPGR4; Nal
r) Sequential (24) 0.95/0.05
WT (B213[pGFP], Gm
r) WT (BPSM; Nal
r) Sequential (24) 0.63/0.37
aSimultaneous and sequential co-inoculation biofilm assays were performed in glass column systems packed with polypropylene beads, which constituted the growth
support.
After 72 h of cultivation, the biofilm cells were detached from the beads and resuspended in PBS. Appropriate dilutions were plated on selective BGA plates containing
Gm or Nal and enumerated. Population of cells of each strain (A or B) is expressed as a percentage of the total population of cells recovered.
doi:10.1371/journal.pone.0028811.t002
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exhibited by each strain without pre-exposure to proteins.
In total, by utilizing a combination of multiple experimental
approaches, we have obtained strong evidence that FHA is
necessary for biofilm formation of B. pertussis on abiotic surfaces.
FHA promotes formation of biofilms in the respiratory
tract
The intranasal mouse model of Bordetella infection is widely
utilized for pathogenic studies and has recently been demonstrated
by us to be a valid and powerful prototype for examining bacterial
biofilm development in vivo [9,10]. Utilizing this model, we have
shown that both B. pertussis and B. bronchiseptica exist as
multicellular communities adherent to the nasal epithelium and
display distinct three dimensional architecture. Moreover, these
biofilms are surrounded by a self-produced extracellular matrix
composed of the Bps polysaccharide thereby satisfying the
definition of in vivo biofilms [9,10]. While the nose has been
clearly established by us to be a site where Bordetella form biofilms,
it is not known whether these bacteria exist in this form in the
trachea. Since FHA promotes efficient attachment of Bordetella to
the ciliated respiratory epithelia and contributes to the coloniza-
tion of the lower respiratory tract [31,49,50], we investigated its
role in the development of multi-cellular biofilm like structure in
the nose and trachea. Based on our in vitro results, which
demonstrate a role for FHA during both attachment and mature
biofilm development, we hypothesized that a similar result would
be obtained in vivo. We therefore examined two time points post-
inoculation, an early time point (1 day) to determine the role of
FHA in direct attachment to the epithelial surface and a late time
point of 7 days. Inoculation with 5610
5 CFUs of wild-type strain
of B. pertussis results in maximal infection of the entire respiratory
tract by seven days and we hypothesize this time point to represent
a mature biofilm phenotype. At 1 and 7 days post-inoculation, the
nasal septum and trachea of mice inoculated with either the WT
or the DfhaB strains were excised and dissected into two equivalent
sections. One section was subjected to analysis of colonization
profiles by enumerating the CFUs, whereas the other section was
examined for the presence of biofilms by probing for B. pertussis
cells adherent to the respiratory epithelium.
Figure 4. Inhibition of association of B. pertussis planktonic cells with the biofilms by anti-FHA serum. GFP-tagged planktonic bacteria of
the WT (BPSM) strain, pre-incubated with SS medium (A) or with (B) dilutions of anti-FHA serum, followed by incubation for 4 h with 24-h-old WT
biofilms. (C) Twenty four-h-old WT biofilms pre-incubated with dilutions of anti-FHA serum, and then subjected to a 4-h incubation period with
planktonic GFP-tagged WT bacteria. GFP-expressing bacteria attached to the biofilms were visualized by acquiring multi-channel (transmitted light
and fluorescence) CLSM images. At least six microscopic fields per coverslips and four coverslips per condition were analysed. A representative
merged image for each condition is shown. The data indicated in the top right of each image are the means 6 standard deviations of the numbers of
GFP-tagged bacteria per 100 mm
2 of pre-formed biofilm microcolony derived from the analysis of twenty four microscopic fields on four coverslips
per condition. The numbers of attached bacteria was determined by examining multi-channel images using ImageJ in conjunction with the ITCN
plug-in.
doi:10.1371/journal.pone.0028811.g004
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observed in the numbers of recovered CFUs of either the WT or
the DfhaB strain from the nose or the trachea (Fig. 6). However,
compared to the nose, both the strains colonized the trachea in
lower numbers. These results are similar to a previous study in
which the maximal number of CFUs harvested from the trachea
one day post-inoculation with the WT strain of B. pertussis was less
than 100 [51]. At seven days post-inoculation and consistent with
previous results, the mutant strain displayed a significantly reduced
ability to colonize the trachea (P=0.00018, Student’s t-test)
[32,52]. However, although there was an overall reduction in
the colonization of the nose by the mutant strain, this difference
was not statistically significant (Fig. 6). We also examined the
colonization of the lungs by these two strains. Both the WT and
the mutant strain colonized the lungs in large numbers and no
statistically significant differences in colonization were observed
either at 1 or 7 days after inoculation.
For examination of biofilms, we chose tissues from infected
animals that showed similar levels of colonization by the WT and
the mutant strains. In addition to visually examine the samples by
CSLM, we also utilized the COMSTAT software to quantitate the
differences in biomass and mean thickness between the WT and
DfhaB strains (Table 3). Examination of nasal septum and trachea
at 1 day post-inoculation, revealed that the WT cells mainly
formed small interspersed clusters on the tracheal and nasal
epithelium (Figs. 7A and 7E). The discrepancy between similar
numbers of CFUs harvested and the observed biofilm phenotype
may be explained by hypothesizing that the WT exists as localized
cell clusters which occupy a small portion of the surface, while the
DfhaB strain is primarily single cells covering a larger surface area
of the epithelia, thereby resulting in equivalent number of cells
being harvested from the two sites. Consistent with this hypothesis,
quantitative analyses using COMSTAT did not reveal any
statistical differences in the biofilm biomass formed over the two
epithelia whereas the mean thickness of the biofilms formed by the
WT strain was greater than that of the biofilms formed by the
mutant strain (Table 3). Control samples, which consisted of nasal
and tracheal tissues from mice infected with PBS, only displayed
reactivity to actin, the epithelia marker (data not shown).
After 7 days of inoculation, the differences in the spatial
arrangement between the DfhaB and WT cells were found to be
markedly more pronounced than those observed one day post-
inoculation for both the organs. Consistent with in vitro data, the
WT strain formed thick, irregularly shaped colonies on focal areas
of the apical surfaces of both the nose and the trachea, resembling
structures that are characteristics of biofilms (Figs. 7C and 7G). In
contrast, the DfhaB strain formed only minute clusters or thin
spikes that did not reach the thickness or the biomass of the
biofilms observed in the WT infected animals (Figs. 7D, 7H and
Table 3).
We also considered the possibility that the observed biofilm
defect of the DfhaB strain could be the result of poor recognition of
this strain by the rat anti-Bordetella serum. To address this caveat,
we carried out immunofluorescence analyses with in vitro grown
cultures grown under Bvg
+ phase conditions. Our results showed
that both the WT and the mutant strains were equally fluorescent,
leading us to conclude that both strains are recognized with similar
efficiency by the rat anti-Bordetella serum (data not shown).
These results not only confirm our previous results documenting
nasal biofilms of B. pertussis [10], but also demonstrate for the first
time that this bacterium can form biofilms in the trachea.
Moreover, these also provide strong evidence highlighting the
critical role of FHA in the formation and maintenance of biofilms
in the mouse respiratory tract.
Discussion
Biofilm formation by the human pathogen B. pertussis is a largely
unexplored field of research and necessitates detailed studies of
factors that regulate this complex developmental program. In the
present study, we sought to gain insights into the structural role of
surface-associated FHA in biofilm formation. Specifically, we
dissected its role in the distinct biofilm developmental stages of B.
pertussis both in vitro, using abiotic substrates, and in the respiratory
tract by employing a murine model of respiratory biofilms.
Figure 5. Association to biofilms of B. pertussis planktonic cells pre-treated with exogenous FHA. GFP-tagged planktonic bacteria of the
WT (BPSM) and DfhaB (BPGR4) strain pre-incubated with SS medium, various concentrations of purified FHA or BSA (20 mgm l
21) followed by
incubation for 4 h with 24-h-old WT biofilms. GFP-expressing bacteria attached to biofilms were visualized by acquiring multi-channel (transmitted
light and fluorescence) CLSM images. The numbers attached bacteria was determined by examining multi-channel images using ImageJ in
conjunction with the ITCN plug-in. The data are the means 6 standard deviations of the numbers of GFP-tagged bacteria per 100 mm
2 of preformed
biofilm microcolony derived from the analysis of twenty four microscopic fields on four coverslips per condition. An asterisk indicates significant
differences between the conditions compared (P value ,0.05; Student’s t-test).
doi:10.1371/journal.pone.0028811.g005
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B. pertussis to accumulate biofilm biomass in vitro. This was
independent of the nature of the surfaces used since this phenotype
was observed on both polypropylene and borosilicate surfaces. In
various bacterial biofilm developmental processes, the functions of
many of the surface proteins such as LapA of P. fluorescens, Type 1
fimbriae of E. coli, and MshA pili of V. cholerae [24,53,54] are
generally restricted to early biofilm stages, essentially to the steps in
which bacteria establish reversible, followed by irreversible,
surface attachment. Our studies in which bacterial attachment
was separated from post-attachment steps revealed that the
impaired biofilm-forming capacity of the DfhaB mutant was not
limited only to the early surface attachment. The lack of FHA
altered the formation of cellular aggregates or biofilms. Micros-
copy studies revealed that in contrast to the robust biofilm
architecture of the WT strain that consisted essentially of thick and
large microcolonies surrounded by open channels, the biofilms
formed by the mutant strain were represented mostly by single
cells dispersed over the surface or by very small cell clusters at late
time points. In addition, our results showed that DfhaB cells were
unable to be integrated with WT cells into the community,
demonstrating that FHA on the surface of the WT bacterium was
unable to compensate efficiently for surface deficiency of FHA on
the DfhaB bacterium. Similar results were obtained for Salmonella
enterica serovar Enteritidis, for which the presence of the BapA
adhesin on the cell surface is required to mediate the incorporation
of bacteria into the biofilm microcolonies [55]. In line with a
major role for surface-associated FHA in formation of Bordetella
biofilms, antibody-mediated blocking of FHA present on either the
planktonic or the biofilm bacteria abrogated the integration of
bacterial cells into the biofilms. We conclude that FHA plays a
crucial role in initial attachment and subsequent development of
highly organized mature biofilms by governing both cell-substrate
and cell-cell interactions.
Surprisingly, we found that free FHA reduced the attachment of
WT bacteria to the biofilms, but did not further reduce the low
residual attachment of the DfhaB bacteria. In addition to being
surface-associated, FHA is also secreted in the extracellular milieu
[30,39]. Naturally secreted FHA might, through inhibition of
bacterial attachment to the biofilms via interaction with FHA or
Figure 6. Colonization of the murine respiratory tract by the WT and DfhaB strains. Groups of five, 6 to 8 week old C57BL/6 mice were
intranasally inoculated with containing 5610
5 CFUs of either the WT or the DfhaB strain in 50 ml. After 1 (A) or 7 (B) days, mice were sacrificed and
colonization was assessed for the nasal septum, trachea, and lungs. Horizontal bars represent the mean for each group. The dashed lines indicate the
limit of detection. The experiment was performed in duplicate with all mice from both experiments being represented. An asterisk indicates
significant differences between the WT and the DfhaB mutant (P value ,0.05; unpaired two-tailed Student’s t-test).
doi:10.1371/journal.pone.0028811.g006
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formation.
Recently, Lasa proposed a group of surface proteins, which
share several structural and functional features, as an important
element of biofilm formation by a number bacterial species [56].
The first member of this group was identified in a S. aureus mastitis
isolate and was named Bap (Biofilm associated protein) [57]. The
authors described common features for all Bap-related proteins: i)
they are present on the bacterial surface; ii) they are of high
molecular weight; iii) they contain a core domain of tandem
repeats; iv) they play a relevant role during bacterial infectious
processes and v) they confer on bacteria the capacity to form a
biofilm. Whereas evidence from a vast number of previous studies
indicates FHA fulfils the first four features [31,42,58,59], the
results of this study show that it also satisfies the last one. Thus, the
demonstrated involvement of FHA at different developmental
events of B. pertussis biofilm formation emerges as an important
aspect of this virulence factor. Remarkably, FHA of Bordetella does
not appear to be an isolated case. The recent finding that other
proteins sharing common features with FHA (i.e., CdrA in P.
aeruginosa, and XacFhaB in Xanthomonas axonopodis pv. Citri) are
involved in biofilm formation [40,41], suggests that an increasing
number of proteins in other bacteria which are non-homologous in
primary amino acid sequence may satisfy many of the structural
and functional attributes of Bap-like proteins.
Despite a large body of information available on the
contribution of surface proteins to biofilm growth on different
artificial surfaces in vitro, little is known about their function in
formation of biofilms in host organs. The product of the pilA gene
of Haemophilus influenzae was shown to function in forming stable
biofilms in the chinchilla middle ear [60]. Because the pilA mutant
led to unstable biomass in the chinchilla ear, it was not possible to
Figure 7. Immunofluorescence microscopy analysis of B. pertussis biofilm formation within the murine respiratory tract. Groups of 6-
week-old C57BL/6 mice were intranasally inoculated with 50 ml containing 5610
5 CFUs of either the WT or DfhaB strain grown under Bvg
+ phase
conditions. Sections of trachea and nasal septum were harvested at 1 or 7 days post-infection from infected animals, immediately fixed, and probed
with rat anti-Bordetella serum followed by a donkey anti-rat secondary antibody conjugated to Alexa Flour 488 (which stains bacteria green). To
determine the localization of the host epithelium, specimens were stained for F-actin using phalloidin conjugated to Alexa Fluor 633 (which stains the
epithelium red). For visualization with CLSM, those tissues corresponding to infected animals that showed similar levels for colonization by the WT
and the DfhaB mutant were chosen. For each specimen, image stacks were obtained from at least ten areas of the trachea and nasal septum. (A–H)
Each micrograph is a Z reconstruction produced from a representative stack of Z-section images.
doi:10.1371/journal.pone.0028811.g007
Table 3. COMSTAT analysis of CSLM images generated from trachea and nasal septum tissues isolated from mice infected with









b Strain WT DfhaB WT DfhaB
Trachea 1 0.594 (0.189) 0.246 (0.138) 0.0615 2.675 (0.689) 0.910 (0.361) 0.017
7 3.15 (0.851) 0.721 (0.243) 0.0089 4.460 (1.221) 1.864 (0.5509 0.0283
Nasal Septum 1 1.187 (0.346) 0.837 (0.293) 0.252 3.042 (0.881) 1.531 (0.286) 0.0475
7 4.861 (1.142) 0.802 (0.195) 0.0037 7.233 (1.509) 1.820 (0.364) 0.0079
aAverage values of parameters obtained from COMSTAT analysis of at least six CLSM image stacks derived from duplicated experiments. Standard errors are given in
parentheses.
bdpi; days post-infection.
cP values were determined using an unpaired two-tailed Student’s t-test.
doi:10.1371/journal.pone.0028811.t003
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B. bronchiseptica, FHA was found to promote colonization and
microcolony formation on the nonciliated olfactory epithelium
[36]. Adherence of Bordetella to cilia is a critical step in the
initiation of a non-invasive mucosal infection. In in vitro organ
cultures, experimental infections of animals and in human
patients, both B. bronchiseptica and B. pertussis preferentially and
sometimes exclusively attach to the ciliated respiratory epithelium
[19,61,62]. In this study, we show that B. pertussis FHA plays an
important role in biofilm growth on ciliated nasal epithelium and
trachea. Previously, we have shown that the observed biofilm-like
structures of B. pertussis are characterized by the production and
co-localization of the Bps polysaccharide, a component of the
biofilm matrix [10]. The present results combined with our
previously published data thus strongly suggest that in addition to
the previously demonstrated role of FHA in promoting adherence
to respiratory tissues [31,63,64], it also plays a role in ensuring the
long-term tissue adherence by formation of surface adherent
biofilm communities in the respiratory tract. This may allow
Bordetella to escape immune defenses operative in the nose and the
trachea.
Although initially described as an adhesin, FHA has now
emerged as a multipurpose virulence factor capable of mediating
B. pertussis invasion of host cells and as an immunomodulatory
molecule [33,34,35]. The current results documenting the
contribution of FHA in the initiation and maturation of B. pertussis
biofilms represent a unique example of the intricate and versatile
role played by a single bacterial virulence factor in the emergence
of a highly successful respiratory pathogen.
Materials and Methods
Bacterial strains and growth conditions
B. pertussis B213, a streptomycin-resistant (Sm
r) derivative strain
of Tohama I (WT) [65]; BPSM, a streptomycin- and nalidixic
acid-resistant (Sm
r; Nal
r) strain derived from Tohama I (WT) [66],
and BPGR4, a BPSM derivative mutant strain lacking expression
of FHA (DfhaB) [43], were used in this study. The DfhaB strain
used for mouse infection studies was also derived from Tohama I
and has been described previously [67]. The strains were cultured
and maintained on Bordet-Gengou agar (BGA) (Difco Laborato-
ries, Detroit, MI) supplemented with 15% (v v
21) defibrinated
sheep blood. For both planktonic and biofilm growth conditions,
bacteria were grown in Stainer-Scholte (SS) broth and under Bvg
+
phase conditions. When appropriate, antibiotics were added to the
media at the followings concentrations: streptomycin (Sm),
100 mgm l




Planktonic cultures were performed by inoculating bacteria into
Erlenmeyer flasks containing SS broth, adjusting the optical
density at 650 nm (OD650) to 0.15 and incubating the flaks at
37uC overnight under shaking conditions (160 rpm).
Green fluorescent protein (GFP) labelling of bacteria
B. pertussis B213, BPSM and BPGR4 strains were transformed
with plasmid pCW504, herein referred to as pGFP, which directs
expression of GFP from a constitutive B. pertussis promoter [46].
Plasmid pGFP was mobilized into various B. pertussis strains by
triparental mating using pRK2013 as a helper plasmid. Ex-
conjugates were selected on BGA plates containing Gm and Sm or
Nal. Randomly selected colonies containing pGFP were grown in
SS broth with Gm and were analyzed for GFP expression using
fluorescence. One of the GFP-expressing clones corresponding to
each of the strains was chosen for experimental analysis. A plasmid
stability test revealed that pGFP was stable over 60 generations of
growth under nonselective pressure.
Attachment and biofilm growth conditions
For quantitative analysis of attachment and biofilm growth of B.
pertussis strains, we utilized glass column systems (w=3 cm,
W=18 cm) packed with polypropylene beads (6 g; w=4.2 mm;
H=2 mm; Petroken, Argentina), which constituted the growth
support. The culture procedure was performed as indicated
previously [11]. Briefly, for each strain or culture condition, four
column systems were inoculated with a 10-mL planktonic cell
suspension at an OD650 of 1.0 (1610
9 CFUs ml
21). Alternatively,
when the number of attached cells for the WT strain was required
to equal the population of initial adherent DfhaB mutant strain, the




21. This inoculum size was determined to result
in a population of initial adherent WT strain similar to that
exhibited by DfhaB strain with a high inoculum (1610
9
CFUs ml
21). Bacterial cells were allowed to attach (static
incubation) to the beads for 4 h at 37uC. After this, beads from
two columns per strain or culture condition were collected and
analysed for bacterial attachment quantifying the adhered biomass
by crystal violet (CV) staining. Cell suspensions of the other two
remaining columns per strain or culture condition were drained to
remove non-adhered cells and replaced by 10 ml of fresh SS
broth. Columns were then incubated aerobically by supplying air
at an appropriate flow rate during 72 h or 96 h (when indicated) at
37uC. The growth media were replaced by fresh ones every 24 h.
After 72 or 96 h (when indicated) of cultivation, the two columns
per strain or culture condition were analysed for biofilm formation
by collecting the beads and quantifying the adhered biomass by
CV staining or viable cell counting.
For viable cell count determination, the adhered cells were
gently washed and detached from beads by slight agitation in PBS
buffer. Serial dilutions of cell suspensions were then plated on
BGA plates. The number of colony forming units per unit area
(CFU cm
22) was calculated considering dilutions, surface area of
the bead and number of beads.
Attachment of WT and DfhaB strains to glass surface was
assayed in petri dishes containing glass coverslips. For each B.
pertussis strain, a 15-ml suspension of GFP-expressing cells [pGFP]
at an OD650 of 1.0 (1610
9 CFUs ml
21) was inoculated into a petri
dish containing 3 coverslips. Bacteria were allowed to attach to the
surface under static conditions for 4 h at 37uC. Then, each
coverslip was carefully washed to removed non-adhered cells, fixed
with 2% (v v
21) glutaraldehyde, and visualized by fluorescence
microscopy.
Biofilm development by WT and DfhaB strains was also assayed
by using a continuous-flow culture system, which consisted of a
chamber (L=75 mm; W=25 mm; H=3 mm) having two glass
surfaces, one being a microscope slide and the other being a glass
coverslip serving as the substratum. Each system was sterilized in
autoclave and dried under a flow of sterilized air. The culture
procedure was performed as indicated previously [12]. Briefly, for
each strain, at least two continuous-flow chambers were inoculated
with 5-ml suspensions of GFP-expressing cells [pGFP] at an
OD650 of 1.0 (1610
9 CFUs ml
21). Bacteria were allowed to attach
for 4 h at 37uC prior to initiating the flow. The sterile SS medium,
which was kept stirred and aerated at 37uC, was pumped through
the flow chambers with a peristaltic pump at a flow rate of
0.1 ml min
21. Biofilms were visualized in situ by fluorescence
microscopy every 24 h for 3 days. Alternatively, to investigate
architectural aspects, biofilms were also examined by Confocal
Laser Scanning Microscopy (CLSM).
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For simultaneous co-inoculation experiments, 5-ml planktonic
cell suspensions at an OD650 of 1.0 (1610
9 CFUs ml
21)
corresponding to the B213[pGFP] (WT, Gm
r) strain were mixed
with similar suspensions of the BPGR4 (DfhaB, Nal
r) or the BPSM
(WT, Nal
r) strains, and then introduced into independent glass
column systems packed with polypropylene beads. The biofilm
experiments were conducted as described above. After 72 h of
cultivation, the number of cells corresponding to each strain was
determined by plating aliquots of appropriate dilutions of the
whole cell population recovered from the polypropylene beads on
selective BGA plates containing Gm for B213[pGFP] (WT) and
Nal for BPGR4 (DfhaB) or BPSM (WT).
In sequential co-inoculation experiments, 10-ml planktonic cell
suspensions at an OD650 of 1.0 corresponding to the B213[pGFP]
(WT) strain were inoculated into two glass column systems and
allowed to establish biofilms on the polypropylene surface for 24 h.
After this, 10-ml planktonic suspensions (OD650=1.0) of the
BPGR4 (DfhaB) or BPSM (WT) strains were independently
inoculated into each system, allowed to attach for 4 h, and then
drained to remove non-adhered cells and replaced by fresh SS
broth. After that, the biofilm experiments were conducted as
described above determining at the 72-h time point the number of
sessile cells corresponding to each strain. Data are presented as
fractions of the total bacteria recovered.
Attachment to pre-formed biofilms
Round glass coverslips (diameter: 12 mm; thickness: 0.13 mm)
were introduced in a 20-ml continuous-flow chamber system. The
system was sterilized in autoclave and dried under a flow of
sterilized air. The biofilm culture chamber was inoculated with a
suspension of BPSM (WT) cells at an OD650 of 1.0
(1610
9 CFUs ml
21). Bacteria were allowed to attach for 4 h
prior to initiating the flow (it removed planktonic bacteria leaving
those attached to the surface). Sessile cells were allowed to form
biofilm for 24 h. Coverslips containing the attached biofilms were
removed from the chamber, rinsed with SS medium, and placed
into individual wells of 24-well microtiter plates. Where indicated,
coverslips were blocked with 1% bovine serum albumin (BSA)
(Sigma, St. Louis, Mo.), washed with SS, and then incubated with
dilutions of an anti-FHA serum (1:1000; 1:500, 1:250) (product
code: 97/564; National Institute for Biological Standards and
Control, UK) for 1 h at 37uC. Next, 500-ml planktonic cell
suspensions (1610
7 CFUs ml
21) of BPSM[pGFP] (WT) or
BPGR4[pGFP] (DfhaB) strains, with or without pre-incubation
for 1 h at 37uC with either dilutions of the anti-FHA serum
(1:1000; 1:500, 1:250) or purified FHA (product code: 90/520,
purity: .98%; NIBSC, UK) (final concentration of 5, 10 and
20 mgm l
21), were added into individual wells of the plate
containing the coverslips. After each pre-incubation step, with
the respective sera or purified FHA, the bacteria or the biofilms
were washed with SS. GFP-tagged bacteria in the planktonic
suspension were allowed to attach to microcolonies on the
coverslips for 4 h at 37uC. Then, non-attached bacteria were
removed by rinsing the coverslips with SS. The samples on the
coverslips were fixed with 2% (v v
21) glutaraldehyde. To visualize
the GFP-expressing planktonic bacteria that remained attached to
the biofilms, multi-channel (transmitted light and fluorescence)
CLSM images were acquired. The attachment level was
determined by enumerating those GFP-tagged bacteria that
colocalize with the biofilms through the analysis of the
multichannel images using ImageJ (U.S. National Institutes of
Health, Bethesda, MD, USA) in conjunction with the ITCN plug-
in and COMSTAT (Heydorn et al., 2000). At least six randomly
selected microscopic fields per coverslips and four coverslips from
four independent experiments were analysed.
Quantification of bacterial attachment and biofilm
formation
B. pertussis cell biomass adhered to polypropylene bead surface
was quantified by crystal violet (CV) staining. The protocol was
adapted from that described by O’Toole and Kolter [68]. When
early attachment and biofilm growth were investigated, sessile
biomass was quantified at 4, 72 or 96 h (when indicated) of
incubation respectively. Briefly, beads with adhered biomass were
gently rinsed twice with PBS to remove non-attached cells, air
dried, and then carefully transferred to glass tubes. Cells were
stained by addition of 4.5 ml of CV 0.1% (w v
21) for 15 min. The
stain was removed by exhaustive washing with distilled water.
Then, 9 ml of decolouring solution of ethanol/acetone (80:20) was
added to each tube. The absorbance of the eluted stain was
measured at 590 nm (A590).
Fluorescence microscopy
Biofilms developed on the base of the flow chambers were
visualized in situ by fluorescence microscopy. Visualization was
conducted at a magnification of 4006or 10006by using a Leica
DMLB microscopy (Leica Microsystems, Wetzlar, Germany)
equipped with a standard Blue/Green/Red filters set (excitation:
400/20, 495/15, 570/50 nm) and with a charge coupled device
(CCD) digital camera. For capturing and displaying of images, the
Leica IM50 software was utilized.
Confocal laser scanning microscopy (CLSM) and image
analysis
To study architectural features of biofilms developed in vitro on
the base of the flow chambers, on coverslips, or formed in vivo on
murine nasal and tracheal tissues, a Zeiss LSM510-Axiovert
100 M confocal laser scanning microscope (Carl Zeiss, Germany)
was used. Stacks of Z-section images were viewed and processed
using the Carl Zeiss LSM5 Image Browser version 3.2.0 and/or
the Imaris Software. Images of in vitro biofilms were acquired from
B. pertussis cells expressing GFP [pGFP]. The detection of the
emitted light was performed by sequentially scanning with settings
optimal for GFP (488-nm excitation with argon laser line and 505-
nm long-pass emission). In each experiment, images were acquired
from random points by using a plan-neofluar 6100/1.3 oil
immersion objective, at 1 mm z-intervals down through the
biofilm. In order to acquire quantitative information of the
mature biofilm structure, CLSM images were analyzed by the
computer program COMSTAT [45]. To obtain statistically
representative results, triplicate experiments of 72 h-old biofilms
were performed.
To visualize in vivo B. pertussis biofilms, bacteria were probed
with rat anti-Bordetella serum followed by a secondary anti-rat
antibody conjugated to Alexa Fluor 488, whereas tracheal and
nasal septum tissues were stained for F-actin using phalloidin
conjugated to Alexa Fluor 633 [9]. The tissues were then mounted
in ProLong 9 Gold anti-fade reagent (Invitrogen, Carlsbad, CA,
USA) in four-chambered cover glass. The detection of the emitted
light was performed by sequentially scanning with settings optimal
for both fluorophores. Images were acquired from at least 10 areas
of each tissue section by using a C-Apochromat 636/1.2W
objective, at 1 mm z-intervals down through the section of the
tissue. Stacks of Z-section images were viewed and processed to
create Z reconstructions using the Carl Zeiss LSM5 Image
Browser version 3.2.0. In order to acquire quantitative informa-
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by the computer program COMSTAT [45].
Animal experiments
Groups of five 6-week-old female C57BL/6 mice (Jackson
Laboratory) were lightly sedated with isoflurane (Butler) and were
intranasally inoculated with either 50 ml of sterile PBS alone or
with 560
5 CFUs of Tohama I or the isogenic DfhaB strain. As
stated above, for animal experiments, the strains were grown
under Bvg
+ phase conditions. Immediately after inoculation of the
animals, an aliquot was plated to ensure that the strains were in
the Bvg
+ phase. At designated times post-inoculation, mice were
euthanized, and the nasal septum, trachea and the lungs were
excised. The nasal septum and the trachea were transversally cut
into two equivalent sections. One of the sections of these two
tissues was fixed in 10% normal buffered formalin, and processed
for microscopy as described below. The remaining section of the
nasal septum and the trachea as well as the lungs were
homogenized in PBS and plated onto BGA plates containing
Sm (50 mgm l
21). Colonies were enumerated after 4 days of
growth at 37uC. All animal experiments were carried out in
accordance with institutional guidelines and were repeated in
duplicate. Statistical analysis was carried using an unpaired two-
tailed Student t test.
Immunofluorescent labelling of B. pertussis biofilms
formed in vivo
Immunofluorescent experiments were carried out as previously
described [9,10]. Briefly, after fixation, one section of nasal septum
and the trachea were washed with PBS. At this step the tracheal
section was carefully split open longitudinally. After this, the
sections of both tissues were blocked with 5% normal donkey
serum for 30 min. The tissues were then incubated with rat anti-
Bordetella serum (1:1,000) for 2 h at room temperature. This serum
was collected from a rat 30 days after inoculation with a Bvg
+
phase-locked derivative of RB50. After this, the tissues were
washed five times with PBS, and subsequently incubated for 2 h at
room temperature with a donkey anti-rat secondary antibody
conjugated to Alexa Fluor 488 (1:200). Samples were again
washed five times and fixed for 30 min in 10% normal buffered
formalin to prevent antibody-antigen dissociation during micros-
copy. Tissues were washed with PBS, permeabilized with 0.1%
Triton X-100, and stained for eukaryotic F-actin with a 1:40
dilution of phalloidin conjugated to Alexa Fluor 633 for 30 min.
Samples were visualized by CLSM as described above. For
visualization, those tissue sections corresponding to infected
animals that showed similar levels for colonization by the WT
and the DfhaB mutant were chosen.
Ethics statement
Animal husbandry and experimental procedures were per-
formed in accordance with Public Health Service policy and the
recommendations of the Association for Assessment and Accred-
itation of Laboratory Animal Care and approved by the Wake
Forest University Health Sciences Institutional Animal Care and
Use Committee.
Supporting Information
Figure S1 Time course of the growth of the B. pertussis
Tohama I derivatives BPSM and B213 in shaking
cultures. Shaking cultures were initiated by inoculating bacteria
into 2 L-Erlenmeyers flasks containing 300 ml of SS broth,
adjusting the optical density at 650 nm (OD650) to 0.1. The flasks
were incubated at 37uC under shaking conditions (160 rpm). One-
milliliter aliquots of cell suspensions were taken every 2 h for OD
measurements.
(TIF)
Figure S2 Biofilm formation by B. pertussis Tohama I
derivatives BPSM and B213 on polypropylene. Biofilm
cultures were performed in glass column systems containing
polypropylene beads. (A) Image of CV-stained cells of BPSM and
B213 strains adhered to polypropylene beads after 72 h of
cultivation in glass column systems. (B) Biofilm biomass accumu-
lated by each strain over the polypropylene beads after 72 h of
cultivation was stained with CV 0.1% (v v
21). The CV stain
associated with cells was solubilized in ethanol/acetone (80:20)
and the resulting solution was subjected to measurement of the
absorbance at 590 nm. The data are the means 6 standard
deviations of three independent experiments.
(TIF)
Figure S3 Biofilm formation by B213[pGFP] and B213
B. pertussis strains on polypropylene. Biofilm cultures were
performed in glass column systems containing polypropylene
beads. (A) Images of polypropylene beads containing adhered cells
of B213[pGFP] and B213 strains which were stained with crystal
violet (Upper panel) or exposed to UV light (Lower panel). (B)
Biofilm biomass accumulated by each strain over the polypropyl-
ene beads after 72 h of cultivation was stained with CV 0.1% (v
v
21). The CV stain associated with cells was solubilized in
ethanol/acetone (80:20) and the resulting solution was subjected to
measurement of the absorbance at 590 nm. The data are the
means 6 standard deviations of three independent experiments.
(TIF)
Figure S4 Association of B. pertussis planktonic cells
with the biofilms after pre-incubated with normal sheep
serum. (A) GFP-tagged planktonic bacteria of the WT (BPSM)
strain, pre-incubated with a 1:250 dilution of normal sheep serum,
followed by incubation for 4 h with 24-h-old WT biofilms. (B) 24-
h-old WT biofilms were pre-incubated with a 1:250 dilution of
normal sheep serum, and then subjected to a 4-h incubation
period with planktonic GFP-tagged WT bacteria. GFP-expressing
bacteria attached to the biofilms were visualized by acquiring
multi-channel (transmitted light and fluorescence) CLSM images.
At least six microscopic fields per coverslips and four coverslips per
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